ATE476501T1 - Verfahren zur reinigung von factor vii - Google Patents

Verfahren zur reinigung von factor vii

Info

Publication number
ATE476501T1
ATE476501T1 AT06700982T AT06700982T ATE476501T1 AT E476501 T1 ATE476501 T1 AT E476501T1 AT 06700982 T AT06700982 T AT 06700982T AT 06700982 T AT06700982 T AT 06700982T AT E476501 T1 ATE476501 T1 AT E476501T1
Authority
AT
Austria
Prior art keywords
factor vii
procedure
purifying factor
purifying
rfvii
Prior art date
Application number
AT06700982T
Other languages
English (en)
Inventor
Rikkle Bolding Jensen
Frank Bech Nygaard
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Application granted granted Critical
Publication of ATE476501T1 publication Critical patent/ATE476501T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Saccharide Compounds (AREA)
AT06700982T 2005-01-14 2006-01-13 Verfahren zur reinigung von factor vii ATE476501T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64412605P 2005-01-14 2005-01-14
PCT/DK2006/000024 WO2006074664A1 (en) 2005-01-14 2006-01-13 Method for purification of factor vii

Publications (1)

Publication Number Publication Date
ATE476501T1 true ATE476501T1 (de) 2010-08-15

Family

ID=36010990

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06700982T ATE476501T1 (de) 2005-01-14 2006-01-13 Verfahren zur reinigung von factor vii

Country Status (10)

Country Link
US (1) US20090047723A1 (de)
EP (1) EP1841863B1 (de)
AT (1) ATE476501T1 (de)
CY (1) CY1110867T1 (de)
DE (1) DE602006015907D1 (de)
DK (1) DK1841863T3 (de)
ES (1) ES2349112T3 (de)
PL (1) PL1841863T3 (de)
PT (1) PT1841863E (de)
WO (1) WO2006074664A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2440810C2 (ru) * 2005-04-28 2012-01-27 Ново Нордиск Хелс Кеа Аг Закрытый контейнер, содержащий активированный полипептид фактора vii, способы его получения и набор и способ применения набора
FR2901796A1 (fr) * 2006-05-31 2007-12-07 Lab Francais Du Fractionnement Procede d'extraction d'une ou de plusieurs proteines presentes dans du lait
SG176283A1 (en) * 2009-06-16 2012-01-30 Genzyme Corp Improved methods for purification of recombinant aav vectors
CA2787009C (en) * 2010-01-15 2018-04-03 Bio-Rad Laboratories, Inc. Surface neutralization of apatite
US8895707B2 (en) * 2010-08-18 2014-11-25 Bio-Rad Laboratories, Inc. Elution of proteins from hydroxyapatite resins without resin deterioration
JP6055412B2 (ja) 2010-09-17 2016-12-27 バクスアルタ ゲーエムベーハー 弱酸性〜中性のｐＨにおける、ヒスチジンを有する水性製剤を介した免疫グロブリンの安定化
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
US9592540B2 (en) 2011-02-02 2017-03-14 Bio-Rad Laboratories, Inc. Apatite surface neutralization with alkali solutions
US9815695B2 (en) 2012-05-30 2017-11-14 Bio-Rad Laboratories, Inc. In situ restoration of apatite-based chromatography resins
WO2013180647A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities
US9175279B1 (en) 2013-03-15 2015-11-03 Csl Limited Method of purifying factor VII and/or factor VIIa
WO2015200282A1 (en) 2014-06-23 2015-12-30 Bio-Rad Laboratories, Inc. Apatite pretreatment
WO2015200299A2 (en) 2014-06-23 2015-12-30 Bio-Rad Laboratories, Inc. Apatite in-situ restoration
JP2019530672A (ja) 2016-09-13 2019-10-24 バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ 第ｖｉｉａ因子グリコフォーム

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473553A (en) * 1983-12-02 1984-09-25 Miles Laboratories, Inc. Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa
US4470969A (en) * 1983-12-02 1984-09-11 Miles Laboratories, Inc. Process for producing a concentrate of coagulation factors VII and VIIa
US4637932A (en) * 1984-10-15 1987-01-20 Miles Laboratories, Inc. Process for producing a concentrate enriched in coagulation factors VII and VIIa
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins
DK38293D0 (da) * 1993-03-31 1993-03-31 Novo Nordisk As Fremstilling af proteiner
DE4406515C1 (de) * 1994-02-28 1995-10-19 Immuno Ag Verfahren zur Isolierung und Reinigung Vitamin K-abhängiger Proteine
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
US6451987B1 (en) * 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
DE19937218A1 (de) * 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
US7897734B2 (en) * 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
US20070037966A1 (en) * 2004-05-04 2007-02-15 Novo Nordisk A/S Hydrophobic interaction chromatography purification of factor VII polypeptides

Also Published As

Publication number Publication date
DE602006015907D1 (de) 2010-09-16
CY1110867T1 (el) 2015-06-10
US20090047723A1 (en) 2009-02-19
WO2006074664A1 (en) 2006-07-20
PL1841863T3 (pl) 2011-05-31
ES2349112T3 (es) 2010-12-28
EP1841863B1 (de) 2010-08-04
DK1841863T3 (da) 2010-11-29
PT1841863E (pt) 2010-10-25
EP1841863A1 (de) 2007-10-10

Similar Documents

Publication Publication Date Title
ATE476501T1 (de) Verfahren zur reinigung von factor vii
DE502006007617D1 (de) Flüssigkeitsabsorption durch metallorganische Gerüstmaterialien
DE602005009856D1 (de) Verfahren zur reinigung von fsh
TW200738270A (en) Method of treating depression using a TNFα antibody
WO2007115837A3 (en) Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule
NO20062087L (no) Bispesifikt antistoff som substituerer for funksjonelle proteiner
ATE498412T1 (de) System zur abgabe von flüchtigen stoffen
NO20063304L (no) Fremgangsmate til a rense FSH
DK1520897T3 (da) Adhæsive strukturer til fastgörelse til hud
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
WO2005105276A3 (en) Device with a membrane on a carrier, as well as a method for manufacturing such a membrane
DE602007006610D1 (de) Isolationsdurchdringendes und SMD fähiges Kontaktelement , sowie Verfahren zu dessen Nutzung.
DE602006008581D1 (de) Verfahren zur bestimmung von montagebedingungen, vorrichtung zur bestimmung von montagebedingungen und montagevorrichtung
WO2007068910A3 (en) Oligomerisation
DE602005013895D1 (de) Vorrichtung zur Herstellung von Reifenbestandteilen.
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
ATE555019T1 (de) Verfahren zur erzeugung flüssiger zubereitungen mit festkörpergehalt
ATE394369T1 (de) Verfahren zur aufreinigung von mesotrion
DK1519944T3 (da) Fremgangsmåder til fremstilling af fibrinogen
DE502005003816D1 (de) System zum Erzeugen von Lenkwinkeln
DE602004022014D1 (de) Rekonfigurierbares Verfahren zur Erfassung von Ereignissen im Fahrzeug
ITTO20050784A1 (it) Ruota per veicoli e procedimento per la sua realizzazione.
TW200644080A (en) Liquid for immersion, purifying method of liquid for immersion, and immersion exposure method
DE602005004863D1 (de) Verfahren zur Punktierung von LDPC Kanalcodes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1841863

Country of ref document: EP